pocketful logo light
pocketful logo light
Bharat Parenterals Ltd logo

Bharat Parenterals Ltd

NSE: BSE: 541096

₹1414

(1%)

Mon, 27 Jul 2026, 04:58 pm

mtf coin illustrationMTF 5x

Bharat Parenterals Share Price Live Chart

1 Day

(1%)

No Result Found

Summary

  • Market Cap (in Cr)

    927.14

  • Net Profit (in Cr)

    -43.68

  • P/B

    2.06

  • Sector P/E

    33.76

  • P/E

    0

  • EV/EBITDA

    56.08

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.81

  • ROCE (Industry)

    16.40

  • RONW (Industry)

    14.39

  • ROE

    -16.55

  • ROCE

    -4.76

  • Debt/Equity

    0.64

  • EPS (TTM)

    0

  • Dividend Yield

    0.07

  • Book Value

    467.55

  • Interest Cover

    -1.62

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters67.1767.1967.1967.1967.20
FII0.110.110.110.110.11
DII1.060.540.540.540.54
Public31.6632.1532.1532.1632.15
Government00000

Read More

Technical Analysis

RSI

60.28

MACD

37.26

50 DMA

1366.60

200 DMA

1198.27

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic1621.671496.671448.331371.671323.331246.671121.67
Fibonacci1496.671448.921419.421371.671323.921294.421246.67
Camarilla1434.381422.921411.461371.671388.541377.081365.63

Pivots Level: Classic

R3

+250

1621.67

R2

+125

1496.67

R1

+76.67

1448.33

1371.67
1371.67
Pivot Point
LTP: 1540

S1

-48.33

1323.33

S2

-125

1246.67

S3

-250

1121.67

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    1454.17

  • 20-EMA

    1422.61

  • 30-EMA

    1400.46

  • 50-EMA

    1361.83

  • 100-EMA

    1295.69

  • 200-EMA

    1252.77

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
18 May 2026board-meetingsAccounts, Quarterly Results, Final Dividend
30 Jan 2026board-meetingsQuarterly Results
04 Sept 2025agm
19 Aug 2025dividendFinal Dividend - Rs. - 119 Sept 2025
12 May 2025dividend₹1.00 Dividend /Share19 Sept 2025
10 Jun 2024agm
25 May 2024dividendFinal Dividend - Rs. - 125 Jun 2024
22 May 2024dividend₹1.00 Dividend /Share25 Jun 2024
29 Apr 2024egm
01 Sept 2023agm

Read More

Peer Comparison

Bharat Parenterals Ltd logo

Bharat Parenterals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Cipla Ltd logo

Cipla Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Read More

Bharat Parenterals Ltd About

Bharat Parenterals as a pharmaceutical company. The Company develops anti-retroviral drugs in the form of tablets, capsules, oral liquids, eye drops, lotion, creams, and injections for the treatment of various diseases. Bharat Parenterals serves clients in India.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1992

Headquarters

CEO

Bharat Kumar R Desai

Employees

Contact

Website icon

Website

http://www.bplindia.in

Email icon

Email

info@bplindia.in

Phone icon

Phone

91-2667-251679

Location icon

Location

Survey No 144 & 146 Haripura, Jarod Samlaya Road Tal Savli, Vadodara, Gujarat, 391520

Read More

Bharat Parenterals Ltd Company History

YearHistory
1992
  • Bhaarat Parenterals was incorporated on 3rd September under part IX of the Companies Act 1956.
  • The company obtained the certificate of Commencement of Business from the Registrar of Companies, Gujarat, Ahmedabad on 9th September.
2021
  • The company received the license and authorization from the Drugs Controller General of India and Central Drugs Standard Control Organisation for manufacturing and marketing Favipiravir Oral Suspension 100Mg/Ml.
2025
  • Bharat Parenterals completed the Paraguay Audit in April.
  • Bharat Parenterals received the Resilient Award from the Southern Gujarat Chamber of Commerce & Industry.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
SETU SECURITIES PRIVATE LIMITEDbulkBuy7527187828 Feb 2025
NEO APEX SHARE BROKING SERVICES LLPbulkSell7527187828 Feb 2025

Read More

Bharat Parenterals Ltd News

Promoter acquires shares in Bharat Parenterals

Promoter Desai Shares and Stock Private Limited acquired 1,356 equity shares worth ₹18.06 lakh on BSE, increasing holding to 39.67%.

26 Jun 2026

companies

Desai Shares acquires 900 shares in Bharat Parenterals

Desai Shares and Stock Pvt Ltd acquired 900 shares, increasing its stake to 39.64% in Bharat Parenterals Limited via open market transactions.

16 Jun 2026

companies

Bharat Parenterals Q4 FY26: Revenue ₹99.6 Cr, Net Loss Widens

Bharat Parenterals posted Q4 FY26 consolidated revenue of ₹99.6 crore vs ~₹100 crore YoY, with net loss at ₹4.8 crore vs ₹4.7 crore loss in Q4 FY25.

18 May 2026

companies

Bharat Parenterals Reappoints Cost & Internal Auditors for FY27

Bharat Parenterals reappointed M/s. Chetan Gandhi & Associates as Cost Auditor and M/s. Dhruvik Parikh & Co. as Internal Auditor for FY26-27, effective May 18, 2026.

18 May 2026

companies

Bharat Parenterals FY26 Results: Standalone PAT ₹1,601.89 L

Bharat Parenterals reported standalone PAT of ₹1,601.89 lakh and consolidated net loss of ₹2,730.56 lakh for FY26. Board recommended ₹1/share dividend. MD&A highlights USFDA & EU-GMP clearances at Innoxel.

18 May 2026

companies

Read More

Open Your Free Demat Account

Enter your phone number